Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Robert H. Collins, John Nemunaitis, Nadine Ognoskie et al.|Journal of Clinical Oncology|1997Cited by 1.3k
Efficacy of Lenalidomide in Myelodysplastic SyndromesAlan F. List, Jerome B. Zeldis|New England Journal of Medicine|2005Cited by 874
<i>TP53</i> suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patientsGisela Cáceres, Alan F. List|Proceedings of the National Academy of Sciences|2013Cited by 53
A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventionsTae–Hoon Shin, Cynthia E. Dunbar, Yifan Zhou et al.|Blood|2022Cited by 38
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic SyndromesGrace Ward, Alan F. List|International Journal of Molecular Sciences|2023Cited by 38